Cuorips Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	260	175	23
Revenue Growth (YoY)	-	660.87%	-
Cost of Revenue	61	7	13
Gross Profit	199	168	10
Selling, General & Admin	455	423	388
Research & Development	334	334	209
Operating Expenses	790	758	598
Operating Income	-591	-590	-588
Interest & Investment Income	6	4	-
Currency Exchange Gain (Loss)	-37	-36	-
Other Non Operating Income (Expenses)	-18	-18	-41
EBT Excluding Unusual Items	-640	-640	-629
Gain (Loss) on Sale of Investments	-8	-1	1
Asset Writedown	-	-	-3
Other Unusual Items	-	-	1
Pretax Income	-648	-641	-630
Income Tax Expense	4	3	2
Net Income	-652	-644	-632
Net Income to Common	-652	-644	-632
Shares Outstanding (Basic)	8	8	7
Shares Outstanding (Diluted)	8	8	7
Shares Change (YoY)	-	8.69%	-
EPS (Basic)	-81.07	-80.48	-85.84
EPS (Diluted)	-81.07	-80.48	-85.84
Free Cash Flow	-	-892	-474
Free Cash Flow Per Share	-	-111.47	-64.38
Gross Margin	76.54%	96.00%	43.48%
Operating Margin	-227.31%	-337.14%	-2556.52%
Profit Margin	-250.77%	-368.00%	-2747.83%
Free Cash Flow Margin	-	-509.71%	-2060.87%
EBITDA	-513.5	-514	-518
EBITDA Margin	-197.50%	-293.71%	-
D&A For EBITDA	77.5	76	70
EBIT	-591	-590	-588

Source: S&P Global Market Intelligence. Standard template. Financial Sources.